6:27 PM ET
Earnings Call
▶ Call
BioMarin Pharmaceutical Earnings Call: Key Takeaways
BioMarin achieved record $1B+ quarterly revenue but lowered full-year guidance due to $70M in international order timing shifts and Middle East geopolitical headwinds, despite strong underlying demand and accelerated Amicus cost synergies.
- Call
- Nov 2, 2026, 4:30 PM ET